New York, NY USA

Our News on Newswise
View All >

Newswise: 6716af948d313_Screenshot2024-10-21153953.png

A Remote-Controlled Car for Cancer Immunotherapy

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.
21-Oct-2024 3:45 PM EDT Add to Favorites

Newswise: 6716712ea2ea2_Screenshot2024-05-07111244.png

Ludwig Lausanne Director George Coukos elected to the National Academy of Medicine

Ludwig Cancer Research congratulates Ludwig Lausanne Director George Coukos on his election to the U.S. National Academy of Medicine (NAM). Among the highest honors issued to clinicians and scientists, membership in the Academy recognizes...
21-Oct-2024 11:15 AM EDT Add to Favorites

Newswise: 67094d64a4e27_Screenshot2024-10-11120046.png

An AI-Powered Pipeline for Personalized Cancer Vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses artificial intelligence...
11-Oct-2024 12:05 PM EDT Add to Favorites

Newswise: 6707ee0c3fdf6_Screenshot2024-10-10104701.png

The Cause of the Genome's Commonest Mutation Has Been Reassigned

A Ludwig Cancer Research study has punctured a longstanding assumption about the source of the most common type of DNA mutation seen in the genome—one that contributes to many genetic diseases, including cancer.
10-Oct-2024 11:05 AM EDT Add to Favorites

Newswise: 66df23686280f_Screenshot2024-09-09121804.png

How the Scars of Demolished Brain Tumors Seed Relapse

A Ludwig Cancer Research study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the fibrous scars of malignant predecessors destroyed by interventions such as radiotherapy, surgery and...
9-Sep-2024 12:05 PM EDT Add to Favorites

Newswise: 66c8e1f712376_Screenshot2024-08-23150103.png

A switch for immune memory and anti-tumor immunity

A Ludwig Cancer Research study has identified a metabolic switch in the immune system’s T cells that is essential to the generation of memory T cells—which confer lasting immunity to previously encountered pathogens—and a T cell subtype found...
23-Aug-2024 3:05 PM EDT Add to Favorites

Newswise: 665dfd68a9b9c_Screenshot2024-06-03130831.png

Two-pronged attack strategy boosts immunotherapy in preclinical studies

A novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged attack against solid tumors to boost the immune system’s ability to target and eliminate cancer cells.
3-Jun-2024 1:05 PM EDT Add to Favorites

Newswise: 663a47cec0777_Screenshot2024-05-07111207.png

AI predicts tumor-killing cells with high accuracy

Using artificial intelligence, Ludwig Cancer Research scientists have developed a powerful predictive model for identifying the most potent cancer killing immune cells for use in cancer immunotherapies.
7-May-2024 10:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Experts

Our Multimedia on Newswise

Facebook

close
0.27631